Asunto(s)

RESUMEN

In this study, we assessed the psychometric properties of the Spanish Patient-Reported Outcomes Measurement Information System (PROMIS) Depression in an adult population-representative sample from Spain (n = 1,503). We tested unidimensionality and local independence item response theory (IRT) assumptions with confirmatory factor and bifactor models under the exploratory structural equations modeling framework. We evaluated item monotonicity assumption with Mokken scaling analysis. We calibrated the items with an IRT-graded response model and assessed score reliability and test information, and evidence of validity with regard to scores on external measures. To examine differential item functioning by age, sex, education, and country (United States vs. Spain, N = 2,271), we used ordinal logistic regression. Results support compliance with IRT assumptions. We found few signs of differential item functioning: Only one item showed country differential functioning between the United States (n = 768) and Spain, with minimal impact on the overall score. Information values were equivalent to reliabilities over 0.90 from -1 (low depression) to +4 SD (high depression) around the population score mean. Evidence of validity in relation to concurrent measures was supported by the expected correlation pattern with external variables of depression, but higher than expected correlations with anxiety were found. Results indicate that the Spanish version of PROMIS Depression is adequate for assessing and monitoring depression levels in the general population and that PROMIS Depression is especially suitable for cross-national comparisons. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Asunto(s)

RESUMEN

Objective: To describe the distribution of role limitation in the European population aged 18-64 years and to examine the contribution of health conditions to role limitation using a public-health approach. Methods: Representative samples of the adult general population (n=13,666) aged 18-64 years from 10 European countries of the World Mental Health (WMH) Surveys Initiative, grouped into three regions: Central-Western, Southern and Central-Eastern. The Composite International Diagnostic Interview (CIDI 3.0) was used to assess six mental disorders and standard checklists for seven physical conditions. Days with full and with partial role limitation in the month previous to the interview were reported (WMH-WHODAS). Population Attributable Fraction (PAFs) of full and partial role limitation were estimated. Results: Health conditions explained a large proportion of full role limitation (PAF=62.6%) and somewhat less of partial role limitation (46.6%). Chronic pain was the single condition that consistently contributed to explain both disability measures in all European Regions. Mental disorders were the most important contributors to full and partial role limitation in Central-Western and Southern Europe. In Central-Eastern Europe, where mental disorders were less prevalent, physical conditions, especially cardiovascular diseases, were the highest contributors to disability. Conclusion: The contribution of health conditions to role limitation in the three European regions studied is high. Mental disorders are associated with the largest impact in most of the regions. There is a need for mainstreaming disability in the public health agenda to reduce the role limitation associated with health conditions. The cross-regional differences found require further investigation (AU)

Objetivo: Describir la distribución de la discapacidad en población europea de 18 a 64 años de edad y analizar la contribución de los trastornos físicos y mentales con una perspectiva de salud pública. Métodos: Se analizaron muestras representativas de población general adulta (n=13.666) de 10 países europeos participantes en la Iniciativa Mundial de Encuestas para la Salud Mental (World Mental Health Surveys Initiative), agrupados en tres regiones: Centro-Oeste, Sur y Centro-Este. La Entrevista Diagnóstica Internacional Compuesta (CIDI 3.0) se utilizó para evaluar seis trastornos mentales, y siete trastornos físicos fueron autorreportados a partir de una lista estandarizada. Se contabilizaron los días con discapacidad parcial y total del mes previo a la entrevista utilizando una versión modificada de la escala WHO-DAS. Se calcularon las fracciones de riesgo atribuible (PAF). Resultados: Los trastornos mentales y físicos fueron importantes contribuyentes a la discapacidad total (PAF=62,6%) y en menor medida a la discapacidad parcial (46,6%). El dolor crónico fue el único trastorno que ha contribuido a explicar tanto la discapacidad total como la parcial en las tres regiones europeas. Los trastornos mentales son los que contribuyen más a la discapacidad total y parcial en los países del Centro-Oeste y del Sur. En los países del Centro-Este, donde los trastornos mentales fueron poco prevalentes, la enfermedad cardiovascular fue la principal contribuyente a la discapacidad. Conclusión: La contribución de los trastornos físicos y mentales a la discapacidad en las tres regiones europeas estudiadas es importante. Los trastornos mentales están asociados con una gran discapacidad en la mayoría de las regiones. Es necesario incorporar el estudio del impacto de las enfermedades comunes en discapacidad a la agenda de salud pública. Se necesitan estudios adicionales que profundicen en las diferencias regionales encontradas (AU)

Asunto(s)

RESUMEN

OBJECTIVE: To describe the distribution of role limitation in the European population aged 18-64 years and to examine the contribution of health conditions to role limitation using a public-health approach. METHODS: Representative samples of the adult general population (n=13,666) aged 18-64 years from 10 European countries of the World Mental Health (WMH) Surveys Initiative, grouped into three regions: Central-Western, Southern and Central-Eastern. The Composite International Diagnostic Interview (CIDI 3.0) was used to assess six mental disorders and standard checklists for seven physical conditions. Days with full and with partial role limitation in the month previous to the interview were reported (WMH-WHODAS). Population Attributable Fraction (PAFs) of full and partial role limitation were estimated. RESULTS: Health conditions explained a large proportion of full role limitation (PAF=62.6%) and somewhat less of partial role limitation (46.6%). Chronic pain was the single condition that consistently contributed to explain both disability measures in all European Regions. Mental disorders were the most important contributors to full and partial role limitation in Central-Western and Southern Europe. In Central-Eastern Europe, where mental disorders were less prevalent, physical conditions, especially cardiovascular diseases, were the highest contributors to disability. CONCLUSION: The contribution of health conditions to role limitation in the three European regions studied is high. Mental disorders are associated with the largest impact in most of the regions. There is a need for mainstreaming disability in the public health agenda to reduce the role limitation associated with health conditions. The cross-regional differences found require further investigation.

Asunto(s)

RESUMEN

OBJECTIVE: We aimed to collect and meta-analyse the existing evidence regarding the performance of the Center for Epidemiologic Studies Depression (CES-D) for detecting depression in general population and primary care settings. METHOD: Systematic literature search in PubMed and PsychINFO. Eligible studies were: a) validation studies of screening questionnaires with information on the accuracy of the CES-D; b) samples from general populations or primary care settings; c) standardized diagnostic interviews following standard classification systems used as gold standard; and d) English or Spanish language of publication. Pooled sensitivity, specificity, likelihood ratios and diagnostic odds ratio were estimated for several cut-off points using bivariate mixed effects models for each threshold. The summary receiver operating characteristic curve was estimated with Rutter and Gatsonis mixed effects models; area under the curve was calculated. Quality of the studies was assessed with the QUADAS tool. Causes of heterogeneity were evaluated with the Rutter and Gatsonis mixed effects model including each covariate at a time. RESULTS: 28 studies (10,617 participants) met eligibility criteria. The median prevalence of Major Depression was 8.8% (IQ range from 3.8% to 12.6%). The overall area under the curve was 0.87. At the cut-off 16, sensitivity was 0.87 (95% CI: 0.82-0.92), specificity 0.70 (95% CI: 0.65-0.75), and DOR 16.2 (95% CI: 10.49-25.10). Better trade-offs between sensitivity and specificity were observed (Sensitivity = 0.83, Specificity = 0.78, diagnostic odds ratio = 16.64) for cut-off 20. None of the variables assessed as possible sources of heterogeneity was found to be statistically significant. CONCLUSION: The CES-D has acceptable screening accuracy in the general population or primary care settings, but it should not be used as an isolated diagnostic measure of depression. Depending on the test objectives, the cut-off 20 may be more adequate than the value of 16, which is typically recommended.

Asunto(s)

RESUMEN

PURPOSE: To examine the association between baseline functional status and any emotional disorder at follow-up, after controlling for potential confounders. The effect modification of previous mental disorders and physical conditions was assessed. METHODS: Data are from the Netherlands Mental Health Survey and Incidence Study-2, a representative population-based, 3-year longitudinal study completed in 2012. Individuals at risk of a new or a recurrent emotional disorder were selected at baseline (n = 4,574). The appearance of any emotional disorder between waves, assessed with the Composite International Diagnostic Interview 3.0, was the outcome. Functional status at baseline was assessed with the physical (PCS) and mental component summary (MCS) of the Short Form-36 Health Survey version 1 and with the number of disability days collected with the World Health Organization Disability Assessment Scale II. Multivariable logistic regression models adjusted by socio-demographic and lifestyle factors were fitted. Interaction terms between previous mental disorders or physical conditions with the predictors were tested. RESULTS: At baseline, 12.1 % had low PCS score, 5.9 % had low MCS score and 30.3 % reported any disability days. The incidence of emotional disorders in 3 years was 9.1 % [95 % confidence interval (95 % CI) 8.1-10.3]. Having low PCS or low MCS at baseline [PCS adjusted OR (aOR) 1.51, p value = 0.02; MCS aOR 1.90, p = 0.002] or reporting more than 15 disability days (aOR 1.63, p = 0.035) was significantly associated with 3-year incidence of emotional disorders. Having a previous mental disorder modified the relationship between MCS and incidence. Among those with a low MCS score, a previous mental disorder considerably increased the risk of incident emotional disorders (aOR 2.72, p = <0.001). CONCLUSIONS: Low functional status is an independent risk factor for developing emotional disorders in the general population. Appropriate identification followed by early intervention may contribute to reduce their associated burden.

Asunto(s)

RESUMEN

BACKGROUND: Brain disorders represent a high burden in Europe and worldwide. The objective of this study was to provide specific estimates of the economic costs of brain disorders in Spain, based on published epidemiological and economic evidence. METHODS: A cost-of-illness study with a societal perspective of 19 brain disorders was carried out. Cost data published between 2004 and 2012 was obtained from a systematic literature review. Direct healthcare, direct non-medical and indirect costs were considered, prioritizing bottom-up information. All costs were converted to Euro and to year 2010. The missing values were imputed with European estimates. Sensitivity analyses based on qualitative assessment of the literature and on a Monte Carlo simulation were performed. RESULTS: The review identified 33 articles with information on costs for 11 disorders (8 neurological, 3 mental). The average per-patient cost ranged from 36,946 € for multiple sclerosis to 402 € for headache. The societal cost of the 19 brain disorders in Spain in 2010 was estimated in 84 € billion. Societal costs ranged from 15 € billion for dementia to 65 € million for eating disorders. Mental disorders societal cost were 46 € billions (55% of the total), while neurological disorder added up to 38 € billion. Healthcare costs represented 37% of the societal costs of brain disorders, whereas direct non-medical constituted 29% and indirect costs 33%. CONCLUSION: Brain disorders have a substantial economic impact in Spain (equivalent to almost 8% of the country's GDP). Economic data on several important brain disorders, specially mental disorders, is still sparse.

Asunto(s)

RESUMEN

Objective: To examine the effects of common mental disorders and physical conditions on role functioning in Spain. Methods: Cross-sectional study of the general adult population of Spain (n = 2,121). Non-psychotic mental disorders were assessed with the Composite International Diagnostic Interview (CIDI 3.0) and physical conditions with a checklist. The role functioning dimension of the WHO-Disability Assessment Schedule (WHODAS) was used to asses the number of days in the past month in which respondents were fully or partially limited to perform daily activities. Generalized linear models were used to estimate individual-level associations of specific conditions and role functioning, controlling for co-morbidity. Societal level estimates were calculated using population attributable risk proportions (PARP). Results: Mental disorders and physical conditions showed similar number of days with full role limitation (about 20 days per year); in contrast mental disorders were responsible for twice as many days with partial role limitation than physical conditions (42 vs 21 days, respectively). If the population were entirely unexposed to mental and physical conditions, days with full limitation would be reduced by 73% and days with partial limitation by 41%. Conclusions: Common health conditions in Spain are associated with considerably more days with role limitation than other Western countries. There is need of mainstreaming disability in the Spanish public health agenda in order to reduce role limitation among individuals with common conditions (AU)

Objetivo: Analizar la discapacidad funcional de trastornos mentales y físicos frecuentes en España. Métodos: Estudio transversal de la población general adulta de España (n = 2121). La evaluación de trastorno mental no psicótico se hizo con la Entrevista Diagnóstica Internacional Compuesta. Los trastornos físicos fueron autorreportados a partir de una lista estandarizada. La dimensión de actividades de la vida diaria de WHO-Disability Assessment Schedule (discapacidad funcional) se utilizó para evaluar el número de días del mes pasado en que los/as participantes presentaron una limitación total o parcial para realizar actividades de la vida diaria. Se ajustaron modelos lineales generalizados para estimar las asociaciones individuales entre trastornos y discapacidad funcional, controlando por comorbilidad. En el ámbito social, se calcularon las proporciones del riesgo atribuible poblacional (PARP). Resultados: Los trastornos mentales y físicos mostraron igual número de días con discapacidad funcional total (20 días/año). En cambio, los trastornos mentales se asociaron al doble de días con discapacidad funcional parcial que los trastornos físicos (42 frente a 21 días, respectivamente). Si la población no estuviera expuesta a los trastornos mentales y físicos frecuentes, los días con discapacidad funcional total se reducirían un 73% y los días con discapacidad funcional parcial un 41%. Conclusiones: Los trastornos mentales y físicos frecuentes están asociados con un mayor número de días con discapacidad funcional en España que en otros países occidentales. Es necesario incorporar la discapacidad en la agenda de salud pública española con el fin de reducir la limitación funcional entre los individuos con trastornos frecuentes (AU)

Asunto(s)

RESUMEN

OBJECTIVE: To examine the effects of common mental disorders and physical conditions on role functioning in Spain. METHODS: Cross-sectional study of the general adult population of Spain (n = 2,121). Non-psychotic mental disorders were assessed with the Composite International Diagnostic Interview (CIDI 3.0) and physical conditions with a checklist. The role functioning dimension of the WHO-Disability Assessment Schedule (WHODAS) was used to asses the number of days in the past month in which respondents were fully or partially limited to perform daily activities. Generalized linear models were used to estimate individual-level associations of specific conditions and role functioning, controlling for co-morbidity. Societal level estimates were calculated using population attributable risk proportions (PARP). RESULTS: Mental disorders and physical conditions showed similar number of days with full role limitation (about 20 days per year); in contrast mental disorders were responsible for twice as many days with partial role limitation than physical conditions (42 vs 21 days, respectively). If the population were entirely unexposed to mental and physical conditions, days with full limitation would be reduced by 73% and days with partial limitation by 41%. CONCLUSIONS: Common health conditions in Spain are associated with considerably more days with role limitation than other Western countries. There is need of mainstreaming disability in the Spanish public health agenda in order to reduce role limitation among individuals with common conditions.

Asunto(s)

RESUMEN

PURPOSE: Indirect costs of mental disorders are considerable and include loss of work productivity. We aimed to study the association between personal annual earnings and common mental disorders in Spain. METHODS: A cross-sectional population study of a representative sample of noninstitutionalized adults from Spain was performed (ESEMeD-Spain). CIDI 3.0 was administered to assess DSM IV mental disorders, and the Sheehan Disability Scales were used for severity appraisal. Four categories of mental disorders were defined: 12-month serious, 12-month moderate, 12-month mild, and lifetime. Personal annual earnings were assessed. Three models were fitted to estimate differences in annual earnings associated with mental disorders, controlling for sociodemographic variables. RESULTS: Prevalence rates of 12-month mental disorders were: mild 4.6%, moderate 3.8%, and serious 1.6%. Respondents with 12-month serious mental disorder (SMD) were less likely to report any earnings compared to those with no mental disorders (OR = 0.16; 95% CI = 0.07-0.34, p < 0.001). The earnings gap associated with SMD at the individual level was 3,935, about 55% less than individuals with no mental disorders. Taking prevalence into account, the societal impact of SMD in Spain was estimated at 1.40 million annually. CONCLUSION: This is the first study in Spain that describes the earnings gap between individuals with and without mental disorders. Despite the low prevalence of SMD, they represent considerable societal-level productivity loss. Prevention and treatment of SMD should improve work productivity.

Asunto(s)

RESUMEN

OBJECTIVE: The aim of this study was to assess the impact of the scientific evidence reported by Women's Health Initiative (WHI) trial on hormone therapy (HT) use in a 10-year follow-up retrospective cohort of women participating in a breast cancer screening program. METHODS: Between 1998 and 2007, a retrospective cohort of participants in a population-based breast cancer screening program in the city of Barcelona (Catalonia, Spain) was assessed. The study population consisted of 50,918 women. Trends in current HT use and the annual rate of new users were analyzed by age group. RESULTS: From 1998, successive annual increases were found in the prevalence levels of HT use in all age groups. In 2002, the prevalence peaked at 11% in 50- to 54-year-olds and at 10.1% in 55- to 59-year-olds, followed by a sudden reversal and a progressive decrease. In 2007, 5 years after the publication of the WHI trial, the HT use decreased by 89.1% in 50- to 54-year-olds, 87.5% in 55- to 59-year-olds, 84.6% in 60- to 64-year-olds, and 66.0% in 65- to 69-year-olds. The percentage of new users also fell substantially after 2002. CONCLUSIONS: HT use decreased during the 5 years after the publication of the WHI. This reduction was especially marked in the first 2 years, when the decrease in new treatments exceeded the number of continuations. In the following 3 years, the decrease was approximately equal in both groups.

Asunto(s)